drugset / Trial / NCT04379713
20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is designed to evaluate the safety and tolerability of 20vPnC in healthy infants.
Timeline
- Start
- 2020-05-21
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 20-valent pneumococcal conjugate vaccine | Vaccine | — | — |
| Comparator | Prevnar 13 | Vaccine | — | — |